FindMyKOL

Hugh McElderry, MD

Enriched profile

Associate Professor, Department of Cardiovascular Disease; Section Chief of Cardiac Electrophysiology · University of Alabama at Birmingham

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Birmingham, AL · Southeast · United StatesSpecialtyClinical Cardiac ElectrophysiologyFocusAtrial Fibrillation
Active KOLFindMyKOL type: EliteLatest publication2026Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Hugh McElderry is Associate Professor, Department of Cardiovascular Disease; Section Chief of Cardiac Electrophysiology at University of Alabama at Birmingham. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 11 Oct 2026

Overview

Updated 27 Oct 2026

Hugh McElderry is Associate Professor, Department of Cardiovascular Disease at University of Alabama at Birmingham. The public record shows 56 publications with 1,063 citations (h-index 16), centered on Atrial Fibrillation. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 16 companies.

  • Top research focus: Atrial Fibrillation
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 16 companies

Generated from the cited public record · current as of 27 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Atrial Fibrillation2 trials

Research focus

OpenAlex concept fingerprint
Atrial Fibrillation

Drugs & molecules

across trials, industry payments and publications
Eliquisgeneric · ApixabanClinical trials—Industry payments4Publications—RimegepantClinical trials—Industry payments4Publications—NirmatrelvirClinical trials—Industry payments2Publications—SotalolClinical trials—Industry payments2Publications—Andexxageneric · Andexanet alfaClinical trials—Industry payments1Publications—Multaqgeneric · DronedaroneClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Biosense Webster, Inc.Clinical trials1Industry payments27Abbott LaboratoriesClinical trials—Industry payments64Boston Scientific CorporationClinical trials—Industry payments47Medtronic, Inc.Clinical trials—Industry payments44Cardiva Medical, Inc.Clinical trials—Industry payments17Medical Device Business Services, Inc.Clinical trials—Industry payments7Pfizer Inc.Clinical trials—Industry payments4ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Clinical trials—Industry payments3Ablacon, Inc.Clinical trials—Industry payments2AltaThera Pharmaceuticals LLCClinical trials—Industry payments2AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Cortex, Inc.Clinical trials—Industry payments1Impulse Dynamics (USA) Inc.Clinical trials—Industry payments1Medtronic Cardiac Ablation SolutionsClinical trials1Industry payments—Sanofi-Aventis U.S. LLCClinical trials—Industry payments1Vital Connect, IncClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
16companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 26 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 26 Oct 2026

16 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    60.4%
    Beta blocker25.6%
    Sotalol55%Metoprolol Succinate25%Carvedilol21%
    Part D<11 patients
    Antiarrhythmic18.4%
    Amiodarone Hcl55%Flecainide Acetate45%
    Part D<11 patients

    + 1 more class in this area

  • Blood & clotting

    34.3%
    Factor Xa inhibitor34.3%
    Eliquis100%
    Part D≥20 patients
  • Metabolism & gastrointestinal

    5.3%
    SGLT2 inhibitor5.3%
    Jardiance100%
    Part D<11 patients
Where care is delivered (Part B)50.1% facility · 49.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Online presence

Updated 26 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/tom-mcelderry-md

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • X / Twitter

    x.com/tommcelderry

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 26 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.